5 years effectiveness of fingolimod in daily clinical practice: results of the non-interventional study PANGAEA

被引：0
|
作者：
Ziemssen, T. [1 ]
Albrecht, H.
Haas, J. [2 ]
Klotz, L. [3 ]
Lang, M.
Lassek, C.
Schmidt, S.
Tackenberg, B. [4 ]
Cornelissen, C. [5 ]
机构：
[1] Carl Gustav Carus Univ Hosp, Dresden, Germany
[2] Jewish Hosp Berlin, Berlin, Germany
[3] Univ Hosp Munster, Munster, Germany
[4] Univ Hosp Giessen & Marburg, Marburg, Germany
[5] Novartis Pharma GmbH, Nurnberg, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P745
引用
收藏
页码：372 / 373
页数：2
相关论文
共 50 条
  • [31] Treatment effectiveness in relapsing remitting multiple sclerosis patients treated for 5 years with fingolimod in clinical practice: interim results from the observational study PANGAEA
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    Ettle, B.
    Schulze-Topphoff, U.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 286 - 287
  • [32] Fingolimod 2012 and 2016: How did the profile of patients treated with fingolimod change? A comparison of two non-interventional studies PANGAEA and PANGAEA 2.0
    Cornelissen, C.
    Kern, R.
    Ziemssen, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 196 - 196
  • [33] PANGAEA: the average German fingolimod patient. Demographics and baseline characteristics from a 5 year non-interventional study of RRMS patients treated with fingolimod
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 695 - 695
  • [34] PANGAEA: The average German fingolimod patient. Demographics and baseline characteristics from a 5 year non-interventional study of RRMS patients treated with fingolimod
    Ziemssen, T.
    Albrecht, H.
    Klotz, L.
    Schmidt, S.
    Schwarz, H-J
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 620 - 620
  • [35] The change of the fingolimod patient profile over time: a comparison of two non-interventional studies PANGAEA and PANGAEA 2.0.
    Cornelissen, C.
    Ziemssen, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 538 - 538
  • [36] The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0
    Ziemssen, Tjalf
    Schulze-Topphoff, Ulf
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [37] Development of former fingolimod study patients in a real world setting: results from the 4 year interim analysis of the non-interventional trial PANGAEA
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 643 - 644
  • [38] Efficacy and tolerability of glimepiride in daily practice - A non-interventional observational cohort study
    Scholz, GH
    Schneider, K
    Knirsch, W
    Becker, G
    CLINICAL DRUG INVESTIGATION, 2001, 21 (09) : 597 - 604
  • [39] Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study
    Leitner, Deborah R.
    Toplak, Hermann
    Kedenko, Ludmilla
    Steinmaurer, Thomas
    Graeff, Verena
    Metzner, Thomas
    Schwaiger, Elisabeth M.
    Prager, Rudolf
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1419 - 1425
  • [40] Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily Practice
    Gerd Laux
    Bettina Barthel
    Göran Hajak
    Matthias Lemke
    Hans-Peter Volz
    Advances in Therapy, 2017, 34 : 895 - 914
12345